Participant characteristics | Coeffa | 95% CI | P-value |
---|---|---|---|
Age per 10 years | − 0.01 | − 0.01, − 0.01 | < 0.001 |
Female (ref male) | −1.68 | − 1.74, − 1.62 | < 0.001 |
Race/ethnicity (ref white) | |||
 Black | −0.75 | − 0.80, − 0.70 | < 0.001 |
 Hispanic | − 0.15 | − 0.21, − 0.08 | < 0.001 |
 Other/missing | −0.13 | − 0.23, − 0.03 | 0.011 |
Hepatitis C virus coinfection | − 0.21 | −0.25, − 0.16 | < 0.001 |
CD4 cell count (cells/mm3) (ref ≥500) | |||
 350–499 | −0.18 | − 0.19, − 0.16 | < 0.001 |
 200–349 | −0.39 | − 0.41, − 0.37 | < 0.001 |
 100–199 | −0.81 | − 0.83, − 0.78 | < 0.001 |
  < 100 | −1.49 | − 1.52, − 1.46 | < 0.001 |
Viral load ≥400 copies/ml | −0.09 | − 0.11, − 0.07 | < 0.001 |
Kidney function (eGFR) (ref > 60) | |||
 30–60 | − 0.15 | −0.16, − 0.13 | < 0.001 |
  < 30 | −1.11 | − 1.15, − 1.07 | < 0.001 |
ART use | − 0.03 | −0.04, − 0.01 | < 0.001 |
BMI (ref 18.5- < 25) | |||
  < 18.5 | −0.24 | − 0.37, − 0.10 | 0.001 |
 25.0 to < 30.0 | 0.24 | 0.19, 0.29 | < 0.001 |
  ≥ 30.0 | 0.16 | 0.10, 0.22 | < 0.001 |
Self-reported smoking (ref never) | |||
 Former | 0.05 | −0.01, 0.11 | 0.055 |
 Current | 0.15 | 0.10, 0.20 | < 0.001 |
Self-reported hazardous alcohol useb | 0.13 | 0.09, 0.18 | < 0.001 |
Self-reported illicit drug usec | −0.19 | −0.24, − 0.14 | < 0.001 |